Galaxy Diagnostics, Inc.
Biotechnology company · Durham, North Carolina, United States
Galaxy Diagnostics, Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2007. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $413,778 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $3 million sold in a notice filed in 2026.
Galaxy Diagnostics at a glance
What does Galaxy Diagnostics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $413,778 in total (2011 to 2018). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $3 million sold (2026).
Frequently asked questions about Galaxy Diagnostics
Where is Galaxy Diagnostics headquartered?
Galaxy Diagnostics, Inc. is headquartered in Durham, North Carolina, United States.
What does Galaxy Diagnostics do?
Galaxy Diagnostics, Inc. is a biotechnology company.
When was Galaxy Diagnostics founded?
The earliest incorporation on record for Galaxy Diagnostics, Inc. is in 2007, according to public company registers.
Similar companies
- Humacyte, Inc.Durham, North Carolina, United States
- Precision Biosciences IncDurham, North Carolina, United States
- Xilis, Inc.Durham, North Carolina, United States
- inSoma Bio, Inc.Durham, North Carolina, United States
- Atsena Therapeutics, Inc.Durham, North Carolina, United States
- Scion Neurostim, Inc.Durham, North Carolina, United States
- Sapere Bio, Inc.Durham, North Carolina, United States
- BioAesthetics CorpDurham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences